THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

GABELLI & Co INVESTMENT ADVISERS, INC.'s Holding History (CIK: 0000932724)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 430,000 Value ($000) $409 Avg Close — Range —
Q1 2021
Shares 430,000 Value ($000) $440 Avg Close — Range —
Q4 2020
Shares 430,000 Value ($000) $406 Avg Close — Range —
Q3 2020
Shares 600,000 Value ($000) $530 Avg Close — Range —
Q2 2020
Shares 600,000 Value ($000) $583 Avg Close — Range —
Q1 2020
Shares 600,000 Value ($000) $585 Avg Close — Range —
Q4 2019
Shares 600,000 Value ($000) $617 Avg Close — Range —
Q3 2019
Shares 600,000 Value ($000) $555 Avg Close — Range —
Q2 2019
Shares 400,000 Value ($000) $347 Avg Close — Range —